Viewing Study NCT04581733


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-01-01 @ 5:46 AM
Study NCT ID: NCT04581733
Status: WITHDRAWN
Last Update Posted: 2023-09-01
First Post: 2020-09-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve)
Sponsor: Zogenix MDS, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-09-30
Start Date Type: ESTIMATED
Primary Completion Date: 2025-03-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-04-30
Completion Date Type: ESTIMATED
First Submit Date: 2020-09-29
First Submit QC Date: None
Study First Post Date: 2020-10-09
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-08-29
Last Update Post Date: 2023-09-01
Last Update Post Date Type: ACTUAL